Secukinumab for treating plaque psoriasis in children and young people [ID1669]

£656.3K GBP

Funder	National Institute for Health Research
Recipient Organization	University of Aberdeen
Country	United Kingdom
Start Date	Feb 11, 2021
End Date	Aug 04, 2021
Duration	174 days
Number of Grantees	1
Roles	Award Holder
Data Source	Europe PMC
Grant ID	`NIHR133489`

Grant Description

To appraise the clinical and cost effectiveness of secukinumab within its marketing authorisation for treating plaque psoriasis in children and young people.